Co-Founder, Chairman & President
CanaQuest Medical Corp
Therapeutic Potential of CBD Formulated Products backed by Science and Pre-clinical Trials for Neuropsychiatric Disorders
The Presentation will be based on Mentanine®, an Omega3 + CBD Master Formulation, that addresses Mental Health Ailments. The presentation will include a description of how the formula works synergistically with significantly increased efficacy while reducing dosage, capable of acting on mental health issues inside the Central Nervous System (CNS) by crossing the Blood Brain Barrier (BBB). Pre-clinical trials also demonstrated that Mentanine® reduces and eliminates the negative side effects associated with high consumption of CBD. As well, the importance of sublingual delivery and bypassing the digestive system and liver will be discussed.